Download The Need to Improve: Introducing Innovations in Existing Vaccine Processes

Ronald Neeleman, Sanofi Pasteur joined us last year at the World Vaccine Congress Europe to present on ‘THE NEED TO IMPROVE: Introducing Innovations in Existing Vaccine Processes’ Download this presentation now to find out more about: Large Companies are Optimized For Stability A turbulent World! Innovation Horizons Simulation of Manufacturing Logistics Anti-counterfeiting Principle of the Virus Counter …And much more! …

Designing the Next Generation of Vaccines

Sylvie Bertholet, PhD Head In vivo Immunology, Novartis Vaccines & Diagnostics joined us last year at the World Vaccine Congress Europe to present on ‘Designing the Next Generation of Vaccines’ Download this presentation now to find out more about: Designing the Next Generation Vaccines What is a self-amplifying mRNA (replicon)? How does SAM work? A Synthetic Flu Vaccine – SAM(H7) …

Clinical results from a Phase I/IIa trial with the chitosan based adjuvant ViscoGel

Guro Gafvelin, Viscogel joined us last year at the World Vaccine Congress Europe to present on ‘Clinical results from a Phase I/IIa trial with the chitosan based adjuvant ViscoGel’ Download this presentation now to find out more about: ViscoGel® – a viscoelastic hydrogel based on chitosan Unique advantages of ViscoGel as adjuvant Model vaccine for Proof-of-concept studies of ViscoGel as …

Advances and developments in safety for biologicals

Ralf Holzinger, CONFARMA France SARL joined us last year at the World Vaccine Congress Europe to present on ‘Advances and developments in safety for biologicals’ Download this presentation now to find out more about: Vaccines : faster & safer Pyrogens – Fever cascade Pyrogen detection and fever induction MAT (Monocyte Activation Test) systems Reaction of Mono Mac 6 to pyrogens …

Jeff Ryel

Requirements for flu virus stock for human administration in clinical trials

Jeff Ryel, RN – SGS Life Science Services joined us last year at the World Vaccine Congress Europe to present on ‘Requirements for flu virus stock for human administration in clinical trials’ Download this presentation now to find out more about: GMP production regulatory requirements Lab quality and safety testing requirements Clinical validation requirements Clinical Case Study …And much more! …

vaccinestoday, world vaccine congress europe

Where is vaccines research heading?

Where is vaccines research heading? Will the focus in future be on preventing childhood diseases or are will likely to see the development of vaccines against diseases affecting other age groups? Will therapeutic vaccines against Alzheimer’s disease or cancers be a major area for innovation?  These are just some of the questions posed by VaccinesToday during the World Vaccine Congress Europe 2013. …